Android app on Google Play

West Pharmaceutical Services, Inc. (WST) Tops Q4 EPS by 4c, Offers FY12 EPS Outlook

February 16, 2012 7:17 AM EST Send to a Friend
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.59, $0.04 better than the analyst estimate of $0.55. Revenue for the quarter came in at $295.4 million versus the consensus estimate of $290.05 million.

West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.37-$2.55, versus the consensus of $2.51.

For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.




You May Also Be Interested In


Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment